Safety and effectiveness of pharmacotherapy for depression in adults who have sustained a traumatic brain injury: a systematic review protocol

Fiona J Clay; Luke A Perry; Amelia J Hicks; Rachel Batty; Catalin Tufanaru; Mahesh Jayaram; Jennie Ponsford; Malcolm Hopwood

doi:10.11124/JBISRIR-2016-003326

Safety and effectiveness of pharmacotherapy for depression in adults who have sustained a traumatic brain injury: a systematic review protocol

JBI Database System Rev Implement Rep. 2017 Sep;15(9):2270-2286. doi: 10.11124/JBISRIR-2016-003326.

Authors

Fiona J Clay¹, Luke A Perry, Amelia J Hicks, Rachel Batty, Catalin Tufanaru, Mahesh Jayaram, Jennie Ponsford, Malcolm Hopwood

Affiliation

¹ 1Department of Psychiatry, Melbourne Neuropsychiatric Centre, The University of Melbourne, Melbourne, Australia 2The Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia 3Monash-Epworth Rehabilitation Research Centre, Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Melbourne, Australia 4Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia 5School of Psychological Sciences, Monash University, Melbourne, Australia 6Professorial Psychiatry Unit, Department of Psychiatry, University of Melbourne, Melbourne, Australia.

PMID: 28902694
DOI: 10.11124/JBISRIR-2016-003326

Abstract

The objective of this systematic review is to synthesize the current evidence on the effectiveness and harms of pharmacotherapy in the management of depression in adults who have sustained a traumatic brain injury.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antidepressive Agents / therapeutic use*
Brain Injuries, Traumatic / complications*
Depression / drug therapy*
Humans
Quality of Life
Systematic Reviews as Topic

Substances

Antidepressive Agents